Lenz Brian
- SEC CIK
- 0001283260
No open-market purchases or sales filed in the past year.
Current role at each company
- ADMA Adma Biologics, Inc.EVP, CFOas of Mar 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lenz Brian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 (view filing) | Aug 15-16 | 2 days | Lenz BrianEVP, CFO | SSale | −389.8K | $4.53 | −$1.77M | −33.3%782.0K after | 2 lots |
| Dec 9, 2022 (view filing) | Dec 9 | Same day | Lenz BrianEVP, CFO | PPurchase | +6.99K | $2.86 | +$20.0K | +0.7%1.03M after | |
| Oct 26, 2021 (view filing) | Oct 25 | 1 day | Lenz BrianEVP, CFO | PPurchase | +30.0K | $1.00 | +$30.0K | +2.9%1.07M after |